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Abstract
Background: Stroke is a leading cause of disability and distress, and often profoundly affects the quality of life of
stroke survivors and their carers. With the support of carers, many stroke survivors are returning to live in the
community despite the presence of disability and ongoing challenges. The sudden and catastrophic changes
caused by stroke affects the mental, emotional and social health of both stroke survivors and carers. The aim
of this study is to evaluate a Stroke and Carer Optimal Health Program (SCOHP) that adopts a person-centred
approach and engages collaborative therapy to educate, support and improve the psychosocial health of stroke
survivors and their carers.
Methods: This study is a prospective randomised controlled trial. It will include a total of 168 stroke survivors and
carers randomly allocated into an intervention group (SCOHP) or a control group (usual care). Participants randomised
to the intervention group will receive nine (8 + 1 booster) sessions guided by a structured workbook. The primary
outcome measures for stroke survivors and carers will be health-related quality of life (AQoL-6D and EQ-5D) and
self-efficacy (GSE). Secondary outcome measures will include: anxiety and depression (HADS); coping (Brief COPE);
work and social adjustment (WSAS); carer strain (MCSI); carer satisfaction (CASI); and treatment evaluation (TEI-SF
and CEQ). Process evaluation and a health economic cost analysis will also be conducted.
Discussion: We believe that this is an innovative intervention that engages the stroke survivor and carer and will
be significant in improving the psychosocial health, increasing independence and reducing treatment-related
costs in this vulnerable patient-carer dyad. In addition, we expect that the intervention will assist carers and
stroke survivors to negotiate the complexity of health services across the trajectory of care and provide practical
skills to improve self-management.
Trial registration: ACTRN12615001046594. Registered on 7 October 2015.
Keywords: Carer, Collaborative therapy, Cost-effectiveness, Dyad, Psychosocial, Randomised controlled trial,
Stroke
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Abbreviations: AQoL-6D, Assessment of Quality of Life-6 dimensions; BFI-10, Big Five Inventory-10 item; BIPQ, Brief
Illness Perceptions Questionnaire; Brief COPE, abbreviated version of the COPE Inventory; CASI, Carers Assessment of
Satisfaction Index; CEQ, Credibility/Expectancy Questionnaire; EM, expectation-maximization; EQ-5D-3L, European
Quality of Life-5 dimensions-3 levels; GSE, General Self-Efficacy Scale; HADS, Hospital Anxiety and Depression Scale;
HCUQ, Health Care Utilisation Questionnaire; MCSI, Modified Caregiver Strain Index; MMRM, Mixed-effects Model,
Repeated Measures; MMSE, Mini-Mental State Examination; MRS, Modified Rankin Scale; OHP, Optimal Health Program;
QALY, quality-adjusted life year; RCT, randomised controlled trial; SCOHP, Stroke and Carer Optimal Health Program;
TEI-SF, Treatment Evaluation Inventory-Short Form; TRIPOD, Translating Research, Integrated Public Health
Outcomes and Delivery; WSAS, Work and Social Adjustment Scale
Background
Stroke is the second leading cause worldwide of death
(11 %) and serious long-term disability [1, 2]. The sig-
nificant burden of stroke extends across individuals,
families and health systems globally [2, 3]. For the carer,
a sudden shift from an acute hospital stay to informal
care is experienced, as a family member or significant
other contends with a new role and a dependent loved
one [4, 5]. Equally important are the healthcare profes-
sionals who administer appropriate medical treatment
and fulfil ongoing management and education roles for
the stroke survivor across the illness trajectory [6]. How-
ever, in an oversubscribed and under-resourced health
environment other innovative support methods are war-
ranted. The Stroke and Carer Optimal Health Program
(SCOHP) will adopt a person-centred approach com-
bining collaborative therapy and care co-ordination to
support and improve the mental and physical health of
stroke survivors and their carers.
Importance of the stroke-survivor-carer dyadic relationship
The strength of the dyadic relationship is crucial for
achieving optimal mental and physical health for both the
stroke survivor and carer. Alongside the stroke survivor,
the carer must adjust to the immediate and long-term
effects that require varying degrees of assistance and a
consequent reduction in occupational and social activities
[4, 7]. The nonprofessional carer role is complex and
under-recognised encompassing information provision,
managing emotions, social support, health maintenance
and problem solving [8, 9]. The new-found role of carer is
accompanied by intricacies and interdependencies in-
cluding potential role reversals and unexpected physical,
cognitive and emotional demands [8–11]. In addition,
studies continue to report that early hospital discharge
combined with a lack of appropriate planning can ad-
versely impact rehabilitation and contribute to carer bur-
den [12, 13]. Subsequently, carers also experience adverse
health effects with high rates of depression, anxiety, in-
creased morbidity and mortality [13–15]. This is of great
concern given that informal carer involvement in rehabili-
tation is imperative to recovery.
Stroke psychosocial interventions
In recent years research into the field of stroke has shifted
from a physical emphasis to include psychological ele-
ments with a focus on carers; however, the stroke sur-
vivor/carer dyad has received minimal attention. Further,
the evidence base regarding the effectiveness of support
interventions for carers and/or stroke survivors is insuffi-
cient and inconsistent, primarily owing to methodological
issues such as the diversity of intervention outcome mea-
surements [6, 16, 17].
One of the most robust published studies was a rando-
mised controlled trial of tailored psychoeducational
modules and skill-building strategies (e.g. hands-on care-
giver training and goal setting) delivered to 300 informal
carers of stroke patients over three to five inpatient ses-
sions and one home visit, which improved survivor and
caregiver outcomes and reduced costs [18]. However,
home visits are not always feasible and the individually
tailored topics and goal setting focused more on the care
of the stroke survivor than on the carer’s own self-care.
A recent critical analysis of 17 caregiver and 15 care-
giver/stroke survivor dyad intervention studies produced
evidence-based recommendations for the implementa-
tion and future design of stroke informal caregiver and
dyad interventions [6]. Based on American Heart Asso-
ciation guidelines for classes and levels of evidence, in-
terventions identified at the highest level of evidence
were those that:
 combine skill-building (e.g. problem solving, stress
management, goal setting) with psychoeducational
strategies
 tailor interventions to the needs of stroke caregivers
based on needs assessments along the continuum of
care
 deliver the program face to face and/or by telephone
(when in-person contact is not possible)
 offer an optimal number of sessions, which is
between five and nine [6].
Unfortunately, few validated psychosocial interven-
tions specific to carers are available, and for those that
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are, the mechanisms of effectiveness are rarely described
[19]. A recent review evaluating the effectiveness of psy-
chosocial interventions for informal carers found limited
evidence regarding the effectiveness of psychosocial in-
terventions, although psychoeducation, consisting of
training in problem solving and stress coping, reduced
depression and improved carer sense of competency at
the trend level [16]. Overall, current limited evidence
points towards more rigorous design of multidisciplinary
psychosocial interventions, sustainability of outcomes
and inclusion of the stroke survivor-carer dyad.
Translating Research, Integrated Public Health Outcomes
and Delivery (TRIPOD)
This randomised controlled trial (RCT) is part of a larger
research program – TRIPOD – which will evaluate our
Optimal Health Program (OHP) across three chronic con-
ditions; namely stroke, diabetes mellitus and chronic kid-
ney disease, including cost-effectiveness analyses. Based
on a collaborative therapy framework [20], the OHP was
originally developed to support people with mental illness
[21, 22]. The initial trial, in an adult mental health service,
demonstrated significant improvements in health and so-
cial functioning, reduced hospital admissions and net cost
savings per patient [22]. A key aspect of collaborative ther-
apy is recognising that ‘recovery’ and chronic models of
health care are not dichotomous [20]. With the intention
of enhancing self-efficacy, self-management, care co-
ordination and quality of life, the OHP has been adapted
within the broader context of chronic disease. Thus, in
the current series of trials our OHP is used to implement
this therapeutic framework to enable clinicians and con-
sumers to work systematically towards the achievement of
optimal psychosocial health outcomes within mainstream
health services [23]. The self-management foundations of
the OHP are particularly relevant for adults affected by
stroke and their carers who face the daily challenge of
managing various and often simultaneous aspects of their
disease such as managing multiple medications, cognitive
training, ongoing appointments, and physiotherapy as well
as coping with the emotional impact of stroke and their
care regimen. This protocol describes an RCT (SCOHP)
that has been designed to evaluate the OHP for those
affected by stroke – survivors and carers.
Qualitative study: informing development of an optimal
health program
Healthcare provider experiences of carers have been
researched, but little is written about how these can in-
form development of support programs. In collaboration
with the National Stroke Foundation, Carers Victoria
and three consumers (one carer and two stroke survivors)
a qualitative study was undertaken to inform development
of an Optimal Health Program (OHP) to support carers of
those who have experienced a stroke [24]. The aims of the
qualitative study were to inform SCOHP by: (1) exploring
healthcare provider perceptions of stroke carer roles and
support needs and (2) examining carer needs across the
stroke care trajectory. To achieve this, we conducted four
semi-structured focus groups (n = 23) of stroke healthcare
providers across acute, subacute, and community reha-
bilitation services. Focus group facilitators used a semi-
structured focus group schedule to guide discussions.
Sessions were then recorded, transcribed, and analysed
using thematic and content analysis. Table 1 shows the
three key themes and sub-themes that emerged from the
data, which highlight the distinct roles of healthcare pro-
viders and carers.
The findings of this study were used to inform the de-
velopment of the OHP, specifically in terms of having:
staged information across the illness trajectory; flexible
support during transition periods; and a balance of prac-
tical tools and empathic communications around the im-
pact of stroke. In summary, the discussions held with
health providers supported the integration of an OHP
for carers within existing stroke care services across
acute and community settings.
Research aims
The aim of the study is to determine whether a stroke-
specific OHP (SCOHP) improves the psychosocial health
of stroke survivors and their carers, compared to usual
care. The primary objective is to identify the impact of
the OHP on levels of self-efficacy and quality of life for
those affected by stroke. Secondary objectives are to
evaluate the impact of the SCOHP on depression, anx-
iety, social and workplace functioning, self-management,
and illness perceptions of and coping with stroke, and
carer strain and satisfaction.
In addition, a health economic cost analysis will be per-
formed, assuming an Australia-wide implementation, to
identify any cost savings of SCOHP over current practice.
Quality-adjusted life years (QALYs) will be measured
using the Assessment of Quality of Life-6D (AQoL-6D)
[25] and European Quality of Life-5 dimensions-3 levels
Table 1 Themes and sub-themes from thematic analysis
Themes Sub-themes
Transition Healthcare provider roles across stages of the stroke
trajectory
Carer transition to a caring role and how this changes
over time
Information Delivery of information by healthcare provider
The carers’ response to information and difficulties
comprehending implications
Impact of stroke Healthcare provider role in supporting the carer
and person with stroke and maintaining hope
Carers’ experiences of the impact of stroke
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(EQ-5D-3L) [26]. Process evaluation using focus groups
will also be conducted with patients and clinicians to as-
sess the effectiveness of the SCOHP, implementation, up-
take and service delivery.
Methods
General design
This is a prospective randomised controlled trial to
evaluate the effectiveness of the SCOHP for improving
the psychosocial health of those who have experienced
stroke and their carers. The SCOHP will be delivered as
an 8-week individualised support program, with an add-
itional booster session, and will be compared to usual
care. Assessments will take place at baseline, 3, 6, and
12 months. The study protocol was approved by the St
Vincent’s Hospital Human Research Ethics Committee
(HREC-A 019/14). An executive steering committee (all
authors) oversees project planning, conduct and ongoing
data collation.
Setting
The study will be conducted at the neurology unit of St
Vincent’s Hospital, a large metropolitan teaching hos-
pital in Melbourne, Australia. Between 2011 and 2012,
737 patients were admitted to St Vincent’s Hospital, with
a principal diagnosis of stroke. The stroke unit at St
Vincent’s Hospital, Melbourne will enable planned re-
cruitment of 168 participants for the SCOHP program
over a 2-year period.
Participants
A total of 84 patients diagnosed with stroke, and 84 carers
of these patients, will be recruited into the RCT. For the
purposes of this study, stroke is defined as cerebral infarc-
tion or parenchymal haemorrhage confirmed by medical
records. The following criteria are to be met for inclusion
into the RCT: (1) diagnosis of stroke for patient or self-
nominated carer of a stroke patient; (2) 18 years or older;
(3) ability to converse in English without an interpreter
or professional assistance; (4) absence of developmental
disability or amnestic syndrome impairing their ability
to learn from the intervention; and (5) absence of ser-
ious comorbid illness, including severe forms of ap-
hasia, as identified by the nurse unit manager, and
cognitive impairment, as identified from medical notes
scoring lower than 24 on the Mini-Mental State Exam-
ination (MMSE) [27]. As the OHP adopts a holistic ap-
proach to managing chronic disease, patients may enter
the program at any stage along the continuum of care.
Power was calculated to detect a medium effect size of
Cohen’s d = 0.50. This was chosen as a clinically meaning-
ful effect size that may be compared with previous RCT
research in the area of chronic disease management pro-
grams [28]. Calculations assumed two primary outcomes
(health-related quality of life and General Self-Efficacy
Scale (GSE) scores), four assessment points (baseline, 3-
month, 6-month, and 12-month), a study-wide type I error
rate (α) of .05, and hence a type II error rate (β) of 0.20
(power of 0.80), a correlation of post-treatment scores with
baseline measurements (ρ) of 0.81, and a two-tailed statis-
tical test [29]. To detect an effect size of Cohen’s d = 0.50,
53 participants in each of the control and intervention
groups will be required. Allowing for up to 20 % attrition,
a total of 168 participants, or 42 carers and stroke survi-
vors in control and intervention groups will be recruited.
Study procedures
Recruitment
Potential patients who have been diagnosed with stroke
and/or their carer will be identified by clinical staff (e.g.
neurologist, nurse) and provided with a study flyer. Pa-
tients and/or carers will be asked permission for a re-
searcher to approach them to discuss the program in
more detail. If agreeable, they will be approached, in-
formed and formally consented by the research assist-
ant. Study fliers will also be posted online through
community organisations and will include contact de-
tails for the research team. Participants from the com-
munity may contact researchers directly to request
Table 2 Primary and secondary outcome assessments and time
points for SCOHP
Carer Stroke survivor
Assessment tools BL 3 6 12 BL 3 6 12
Primary outcomes
AQoL-6D (20 items) X X X X X X X X
GSE (10 items) X X X X X X X X
Secondary outcomes
BIPQ (8 items) X X X X
Brief COPE (28 items) X X X X X X X X
CASI (30 items) X X X X
CEQ (6 items) X X
EQ-5D -3 L (6 items) X X X X X X X X
HADS (14 items) X X X X X X X X
HCUQ (10 items) X X X X X X X X
MCSI (13 items) X X X X
TEI-SF (9 items) X X
BFI-10 (10 items) X X
WSAS (5 items) X X X X X X X X
AQoL-6D Assessment of Quality of Life-6 dimensions, GSE General Self-Efficacy
Scale, BIPQ Brief Illness Perceptions Questionnaire, Brief COPE abbreviated
version of the COPE Inventory, CASI Carers’ Assessment of Satisfaction Index,
CEQ Credibility/Expectancy Questionnaire, EQ-5D-3L European Quality of
Life-5-dimensions-3 levels, HADS Hospital Anxiety and Depression Scale, HCUQ
Health Care Utilisation Questionnaire, MCSI Modified Caregiver Strain Index,
TEI-SF Treatment Evaluation Inventory-Short Form, BFI-10 Big Five Inventory-10
item, WSAS Work and Social Adjustment Scale
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further information. Planned recruitment will occur
over an 18-month period (see Fig. 1).
Consent
The process of consent will be in accordance with the
Declaration of Helsinki. Nurse unit managers were con-
sulted to determine a patient’s eligibility for the study.
Senior clinicians and the research team were consulted
in instances when it was unclear if an individual met
the inclusion criteria. All eligible patients and carers
will be fully informed that they are being asked to par-
ticipate in an RCT. The procedures involved in the
study, and the chances of being assigned randomly to
one of two groups will be explained verbally and via an
information sheet approved by the hospital’s Human
Research Ethics Committee. A signed consent form
will be obtained from each participant. Participants
will be made aware of their right to withdraw from the
study at any time without any effects on their clinical
management.
Randomisation and blinding
Using a computer-generated block randomisation se-
quence created by a researcher independent of the study,
participants will be allocated to treatment or control
group. The allocation sequence will be generated using
random numbers and participants will be randomised
progressively as they consent. Patients and carers will be
randomized as dyads. Patients or carer will be random-
ized alone if they are not participating as a dyad. Due to
the nature and length of the intervention, it is not pos-
sible to blind either participant or investigator to the
treatment allocation.
Intervention: SCOHP
The SCOHP is delivered at a nominated place of conveni-
ence by the participant i.e. home, hospital, community
health centre. Dyads have the option of either receiving
the intervention independently or together. The SCOHP
comprises a modular format of eight sequential sessions
plus a booster, based on a structured workbook. Partici-
pants are encouraged throughout the program to identify
Inclusion criteria met
Informed consent and baseline assessment
Randomisation
Stroke patient
OHP group
n=42
Stroke patient
control group 
n=42
3-month follow-up assessment
Assessment of eligible stroke patients and carers
6-month follow-up assessment
12-month follow-up assessment
Carer
OHP group 
n=42
Carer
control group 
n=42
Excluded from study
Declined to participate
Fig. 1 Flowchart of the Stroke and Carer Optimal Health Program (SCOHP) randomised controlled trial (RCT)
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areas of stroke- or carer-related health concerns on which
they would like to focus. Sessions are approximately 1 hour
in duration and held weekly, apart from the ‘booster’ ses-
sion, which is held 3 months after session 8. Learning is
cumulative with each session designed to build on the
previous session including tasks to complete between ses-
sions, i.e. journaling and coping strategies (e.g. breathing
exercises).
In summary, session 1 introduces SCOHP within the
six domains of the ‘Optimal Health Wheel’: social, phys-
ical, emotional, intellectual, employment and spiritual as
documented in the workbook. This session provides
participants with the opportunity to explore and under-
stand stroke self-management behaviour from a holistic
perspective. Sessions 2 and 3 initiate development of a
health plan exploring the implications and potential
complications of stroke in terms of strengths and vulner-
abilities, and understanding and monitoring disease im-
pact (e.g. emotional burden and physical weakness).
Session 4 focuses on medication management and meta-
bolic monitoring. Session 5 expands the health plan to
include key stroke partnerships and supports in the
community and online (e.g. www.strokefoundation.co-
m.au). Change enhancement is the focus in session 6, in
terms of understanding past events and establishing new
proactive avenues for change. The aim of session 7 is
goal setting via creative problem solving and planning
around the complexities of stroke. To cement a shift in
focus of the person’s illness from being ‘dependent on’
services to being ‘supported by’ services, session 8 strate-
gises stroke advanced care planning that incorporates
wellbeing maintenance and sustainability. The goal of
the ‘booster session’ (session 9) is to review health plans,
consolidate progress, and reflect on achievements to-
wards health-related goals.
A health professional (e.g. nurse, psychologist) trained
in the approach (2-day workshop plus regular supervi-
sion and fidelity checks) will facilitate each session. The
facilitator will draw on carer and stroke-specific infor-
mation in concordance with individual circumstances.
Examples include the relationship between depression
and caregiving or physical impairments of stroke, avail-
ability of stroke and carer supports in the community,
and coping strategies for addressing anxiety and stress
related to new roles and circumstances. The emphasis is
on collaboration between facilitator and participant to
arrive at goals for the program that stem from the par-
ticipant’s main concerns and needs. The facilitator will
encourage participants to identify their early warning
signs of stress and illness and integrate healthy coping
strategies to prevent the build-up of stress. Facilitators
may also discuss and arrange referrals for other services in
conjunction with the multidisciplinary team depending on
participant needs. Additionally, facilitators will work with
the multidisciplinary team to coordinate visits. Partici-
pants in rural and regional areas will have the option of
participating in sessions via phone or Skype.
Control
The comparison group will receive usual care and no
SCOHP intervention. As participants will be recruited
from a variety of settings (hospital outpatients, commu-
nity organisations) we anticipate variation in standard
care received. To capture this variation, all participants
will complete the Health Care Utilisation Questionnaire
(HCUQ) [30] at each time point. Participants in the
control group will have the option of completing the
SCOHP at the end of the trial once evaluation is
complete.
Outcome measurements
Table 2 details the primary and secondary outcome mea-
sures and time points for carers and stroke survivors.
Participants complete the measures independently un-
less a specific request is made for assistance e.g. due to
vision or motor skill impairment. Primary outcome mea-
sures for both stroke survivors and carers are quality of
life and self-efficacy. Health-related quality of life will be
assessed using the (AQoL-6D) [25], which consists of six
dimensions of health and a global ‘utility’ score and the
EuroQol-5D (EQ-5D) [26]. Self-efficacy is to be assessed
using the General Self-Efficacy Scale (GSE) [31] a meas-
ure of perceived self-efficacy in response to daily chal-
lenges and stressful life events. Secondary measures for
both stroke survivors and carers are: coping strategies as
measured using an abbreviated version of the COPE inven-
tory, the Brief COPE [32]; symptom severity and caseness
of depression and anxiety disorders as assessed using the
Hospital Anxiety and Depression Scale (HADS) [33]; a 10-
item measure of the Big Five personality dimensions (BFI-
10) [34]; effect of an individual’s mental health on their
ability to function via the Work and Social Adjustment
Scale (WSAS) [35]; treatment expectancy and rationale
credibility of the clinical study as assessed with the Cred-
ibility/Expectancy Questionnaire (CEQ) [36]; perceived
satisfactoriness of treatment as assessed using the Treat-
ment Evaluation Inventory-Short Form (TEI-SF) [37]; and
health care utilisation and its economic impact assessed by
the Health Care Utilisation Questionnaire (HCUQ) [30].
Stroke survivors will also be assessed for cognitive and
emotional responses to stroke using the Brief Illness Per-
ceptions Questionnaire (BIPQ) [38]. In addition, carers will
be assessed for carer strain using the Modified Caregiver
Strain Index (MCSI) [39] and carer satisfaction as assessed
by the Carer Assessment of Satisfaction Index (CASI) [40].
Due to the potential for variability of ‘usual care’ in
the control group, key aspects of usual care will be
assessed with the HCUQ. Furthermore, medical records
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will be reviewed to determine stroke diagnostic informa-
tion and clinical indices including the Modified Rankin
Scale (MRS), which measures the degree of disability/de-
pendence after a stroke.
Program assessment and treatment fidelity
The SCOHP facilitators will be trained in program deliv-
ery, receive a structured manual/protocol and monthly
group supervision with the clinical investigators (with
individual supervision provided as needed in between
group sessions). The purpose of supervision will be to
discuss problems in study procedures and ensure stan-
dardised activity. The SCOHP sessions will be audio re-
corded with a random selection rated by independent
assessors in compliance with the SCOHP protocol. Vari-
ations from the protocol will be identified and relayed to
the facilitator. Facilitators will complete a summary of
each session using a standard template and send these
notes to the research team. Session notes will include
OHP topics covered, participant concerns raised, and
needs for supervision. Additionally, content of sessions
regarding participant requirement and concerns will be
discussed at supervision meetings.
Post-intervention focus groups will be held for clini-
cians and participants. Participants will be informed dur-
ing consent (both written and verbal) of the option to
participate in focus groups, and that the purpose is to
ascertain an in-depth understanding of their experiences
of the study, advantages and disadvantages of conducting
the study/program in their services (for clinicians), and
recommendations for components to include or exclude
from the SCOHP. It will be made clear to participants
when consenting that the number of focus groups will
be limited; such that they will only be run until data sat-
uration is achieved. It is envisioned that data saturation
will be reached after 2 to 3 focus groups, each contain-
ing 8 to 12 individuals. To increase objectivity, focus
group facilitators will be independent researchers who
were not OHP facilitators. The pragmatic data analysis
approach of Halcomb and Davidson [42] will be used for
the purpose of focus group data analysis. In summary,
identifying key passages and words will be independently
analyzed, coded, and categorized (classifying key pas-
sages and words within themes) drawing on pragmatic
thematic analysis to form emergent themes.
Statistical analyses
Intention-to-treat analyses will be employed to prevent
overestimation of efficacy. Categorical variables will be
analysed using chi-squared tests (or Fisher’s exact test for
small samples). A mixed-effects model, repeated measures
(MMRM) approach will be used to examine the longitu-
dinal profile of continuous variables at 3, 6 and 12 months
post-baseline. For all MMRM analyses, baseline scores will
be used as covariates and the models will include prespe-
cified fixed effects of treatment, clinician, and time, and
treatment-by-time and treatment-by-clinician interactions.
Secondary analyses using analysis of covariance will
be conducted to compare change scores during treat-
ment and follow-up phases for primary, secondary, and
process outcomes using the fixed, continuous covariate
of baseline score as well as the categorical fixed effects
of treatment group, clinician, and treatment-by-clinician
interactions.
Although the attrition rate is not expected to vary by
treatment condition, we will attempt to identify key pre-
dictors of attrition status (i.e. demographic and baseline
clinical characteristics) and test for differences between
conditions. Assuming the data are missing at random,
several procedures offer effective approaches that may
attenuate attrition. Maximum likelihood models (i.e.
MMRM), with time as a random variable, allow the use of
all available data from all assessments, reducing bias and
increasing power [43]. In addition, multiple imputation
procedures that utilise the expectation-maximization (EM)
algorithm with bootstrap estimates of standard errors will
be used to address attrition. The application of these pro-
cedures can provide unbiased estimates, even in the face
of substantial missing data [44].
A full economic evaluation will occur alongside the
proposed RCT. Healthcare outcomes and costs will be
compared between participants in the control and inter-
ventional conditions. Healthcare system (medical record)
and self-reported information via the HCUQ [30] will be
used to generate analyses. The utility measurements of
participant quality of life will be assessed using AQoL-
6D [25] developed in Australia and the EQ-5D-3L [26]
developed in Europe. The potential long-term (lifetime)
impact on cost and effectiveness of intervention beyond
the trial period will be extrapolated using the Markov
process modelling method.
Discussion
Stroke can carry severe consequences for the patient
and their informal carers or family members who often
feel inadequately prepared to deal with the physical, cog-
nitive and emotional demands [1–3]. Carers experience
adverse health effects with high rates of depression [13],
anxiety [14] and mortality [15]. The informal caring
role is pivotal in maintaining stroke survivors in the
community but this comes at a significant cost to the
carer [4, 9–12]. It is therefore important to develop
programs that will support the carer’s coping and min-
imise the level of burden and ill-health they experience.
The crucial evidence gap lies in the integration and
co-ordination of patient and carer support programs
within health service delivery. Integral to SCOHP is its
integration of carer and patient support within health
Brasier et al. Trials  (2016) 17:446 Page 7 of 9
services from acute to community care. Engaging with
multiple clinicians can be a daunting task, both for pa-
tients and informal carers. The SCOHP assists in nego-
tiating this complexity by adopting a person-centred
approach across the patient trajectory. In addition, stroke
survivor and stroke carer psychosocial health is rarely
studied as a dyad, thus this RCT is expected to make a sig-
nificant contribution to improve the mental health and
wellbeing of patients who have experienced stroke and
their carers.
There are several strengths to this study protocol. Pri-
marily, in the inclusion of the ‘patient-carer dyad’ tailored
to each individual, for both intervention and assessment
purposes. Integration and rollout of the RCT in a clinical
setting was purposefully incorporated to identify the
adaptability of the intervention to a ‘real-world setting’, i.e.
co-ordination and communication between departments.
If successful, the simultaneous evaluation of RCTs across
three of the most burdensome chronic conditions will
provide evidence for the potential applicability of the
intervention to extend to other chronic diseases. To our
knowledge this is the first trial to include a comprehen-
sive health economic cost analysis in the assessment of
an educational, psychosocial intervention aimed at im-
proving the mental and physical health of stroke survi-
vors and their carers.
This series of trials follows common ethical principles
applied in RCTs. Participants receive verbal and written
information before consenting and before study proce-
dures, they are not exposed to any risks, participation is
voluntary and they may withdraw at any time without
reason and without their usual care being affected in any
way. Participants in the control group are also offered
the intervention at the end of the follow-up period.
Trial status
Patient recruitment was ongoing at the time of manu-
script submission. Data collection will continue until at
least December 2017.
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